REGISTERED
on 28 May 2024
Last Applicant/ Owned by
Vancouver BC V6T 1Z3
CA
Serial Number
79352347 filed on 18th Jul 2022
Registration Number
7393905 registered on 28th May 2024
Correspondent Address
Jeffrey A. Smith
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
LCLNP
Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for th Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development services; pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; pharmaceutical formulation development services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Lipid-based pharmaceuticals, namely, lipid-based drug delivery vehicle preparations in the form of lipid formulations that facilitate the delivery of pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancer, infectious diseases, genetic disorders, inflammation and immunological disorders, and for reducing symptoms associated with aging; nucleic acid-based pharmaceuticals, namely, DNA- and RNA-based pharmaceuticals for the diagnosis, treatment or prevention of diseases and disorders, namely, cancers, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; small molecule pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging; protein- and peptide-based pharmaceuticals for use in the diagnosis, treatment or prevention of cancer, infectious diseases, genetic disorders, inflammation and immunological disorders and for reducing symptoms associated with aging
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79352347
Mark Type
No Service Mark
Attorney Docket Number
No LAMV-0004-T
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Nov 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| 10th Nov 2024 | FINAL DISPOSITION PROCESSED |
| 28th Aug 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| 28th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 28th May 2024 | REGISTERED-PRINCIPAL REGISTER |
| 01st Apr 2024 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| 13th Mar 2024 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| 13th Mar 2024 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| 12th Mar 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Mar 2024 | PUBLISHED FOR OPPOSITION |